WRN and breast carcinoma: However, despite minor limitations in the present study, such as a hospital-based study design, restriction to a limited population, and limited statistical power, our results provide new support for an impact of Cys1367Arg on the putative function of RECQL2 as a breast cancer tumor suppressor.